Cleveland Clinic

This is your central portal for breaking news, the latest research and important updates from Cleveland Clinic. Bookmark this page and check back often for updates.

Meeting News

Adjuvant chemotherapy offers limited benefit for invasive lobular carcinoma

December 13, 2019
SAN ANTONIO — Adjuvant chemoendocrine therapy did not extend survival compared with endocrine monotherapy for patients with invasive lobular…
Cover Story

In obesity, growing CV risk burden demands cross-specialty collaboration, new solutions

Cardiology Today, December 2019
The prevalence of obesity in the U.S. is rising at an alarming rate, as are its CV consequences, a result of greater consumption of high-calorie…
Meeting NewsPerspective

Minor kidney dysfunction should not preclude African Americans with AML from enrolling on clinical trials

December 7, 2019
ORLANDO — Although abnormal kidney function appeared more common among African American patients with acute myeloid leukemia than their white…
Point/Counter

Should there be more focus on the financial relationship itself rather than its disclosure?

HemOnc Today, November 25, 2019
POINT The literature has shown that disclosure does not prevent a conflict of interest or bias. The main concern about conflict of interest is that it…
Feature

‘Reproducibility crisis’ in radiation biology research could negatively impact clinical care advances

November 20, 2019
The scientific method is the cornerstone of all scientific advancement. By following clearly outlined methods used during an investigator’s…
Cover Story

HF pharmacotherapy in midst of paradigm shift

Cardiology Today, November 2019
Dramatic results of the recent DAPA-HF and PARAGON-HF trials have prompted the cardiology community to rethink pharmacotherapy for patients with HF…
Pharmacology ConsultPerspective

CV controversy of ADHD medication use in children and adolescents

Cardiology Today, November 2019
Sarah Mehringer, PharmD, BCPS, BCCP; Myaa Lightfoot, PharmD; Katie Liveoak, PharmD, BCPP; Jonathan Bain, PharmD, BCCCP, BCPS (AQ Cardiology)
ADHD affects approximately 11% of school-aged children every year, and this rate continues to rise annually. The primary treatment modality includes…

Cleveland Clinic appoints breast medical oncology director

October 26, 2019
Halle Moore, MD, has been appointed director of breast medical oncology at Cleveland Clinic. Moore also will serve as co-director of the…
Editorial

Immunoautonomics: Can We Hack the Power of the Autonomic Nervous System?

Healio Rheumatology, October 2019
Leonard H. Calabrese, DO
I am extremely excited to showcase our roundtable on immunoautonomics this month. Our thought leaders — including Mark C. Genovese, MD, David

Cleveland Clinic appoints hematology/medical oncology department chair

October 20, 2019
Cleveland Clinic appointed Jame Abraham, MD, FACP, as the new chair of its hematology/medical oncology department. Abraham — who succeeds…
In the JournalsPerspective

Adjuvant whole-brain radiotherapy ‘should not be recommended’ for certain patients with melanoma brain metastases

October 17, 2019
Patients who underwent definitive local treatment of one to three melanoma brain metastases did not attain significant clinical benefit from adjuvant…
Cover Story

Social media ‘tears down walls’ in medicine

HemOnc Today, October 10, 2019
The social media landscape is changing constantly and influencing all realms of society — and health care is no exception. Approximately seven…
Feature

Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Imagine a young adult male in his late 20s picks up his cell phone and calls his mother. Overtly emotional and on the verge of releasing a full-out…
Feature

Cleveland Clinic Cancer Institute outlines approach to address patient financial burden

October 9, 2019
A white paper issued by Cleveland Clinic Cancer Institute describes the organization’s patient-focused approach to addressing issues related to…

ASH presents bridge grants to 19 investigators

October 7, 2019
ASH awarded $150,000 each to 19 investigators through the society’s bridge grant program, designed to sustain promising hematologic research…
Meeting NewsPerspective

Durvalumab reduces local, distant progression in non-small cell lung cancer

September 19, 2019
Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III…
Cover Story

Stem Cell Therapy: Preparing for its Closeup in IBD

Healio Gastroenterology, September 2019
Research into the use of cell-based therapies as possible treatment options for various diseases exploded over the last several years. One of the…
Editorial

Rheumatology in the Blink of an Eye

Healio Rheumatology, September 2019
Leonard H. Calabrese, DO
I am feeling rather nostalgic at the moment. Perhaps it’s just because summer is drawing to a close and autumn is on its way. No? Perhaps…
Cover Story

Out for Blood: Biomarkers Paving the Road to Personalized Medicine for Rheumatic Diseases

Healio Rheumatology, September 2019
There are endless idioms about blood. It is thicker than water, but one cannot get it from a stone. Truman Capote wrote about the cold version, rock…
Meeting NewsPerspective

Radiation improves outcomes with pembrolizumab for metastatic lung cancer

September 17, 2019
The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…